Ligand Pharmaceuticals (LGND) Net Income - Minority (2014 - 2015)
Ligand Pharmaceuticals' (LGND) quarterly Net Income - Minority came in at $2.8 million in Q1 2015, up 44.14% quarter-over-quarter from $1.9 million in Q4 2014.
Ligand Pharmaceuticals (LGND) Net Income - Minority (2014 - 2015) Analysis & Trends
Ligand Pharmaceuticals has disclosed Net Income - Minority across 2 years of filings, most recently posting $2.8 million for Q1 2015.
- Net Income - Minority for Q1 2015 came in at $2.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2015 was $2.8 million (changed N/A YoY), and the FY2014 annual result was $1.9 million, changed N/A from the prior year.
- Net Income - Minority came in at $2.8 million for Q1 2015 at Ligand Pharmaceuticals, up from $1.9 million in the prior quarter.
- In the past five years, Net Income - Minority ranged from a high of $2.8 million in Q1 2015 to a low of $1.1 million in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 2.75 Mn |
| Dec 31, 2014 | 1.91 Mn |
| Sep 30, 2014 | 1.59 Mn |
| Jun 30, 2014 | 1.08 Mn |